⌘K

Login Start Free

Home/Filings/4/0001465822-16-000001

4//SEC Filing

ELITE PHARMACEUTICALS INC /NV/ 4

Accession 0001465822-16-000001

$ELTPCIK 0001053369operating

View on SEC.gov Company Profile

Filed

Apr 14, 8:00 PM ET

Accepted

Apr 15, 3:13 PM ET

Size

10.8 KB

Accession

0001465822-16-000001

Insider Transaction Report

Form 4

Period: 2016-04-13

ELITE PHARMACEUTICALS INC /NV/ELTP

NARINE JEENARINE

Director10% Owner

Transactions

Conversion
Warrants
2016-04-13−2,424,333→ 0 total
Exercise: $0.06From: 2009-06-15Exp: 2016-06-15→ Common Stock (2,424,333 underlying)
Conversion
Warrants
2016-04-13−1,242,334→ 2,935,986 total
Exercise: $0.06From: 2009-10-30Exp: 2016-10-30→ Common Stock (1,242,333 underlying)
Conversion
Common Stock
2016-04-13$0.06/sh+4,000,000$250,000→ 16,742,395 total
Conversion
Warrants
2016-04-13−333,333→ 0 total
Exercise: $0.06From: 2009-06-03Exp: 2016-06-03→ Common Stock (333,333 underlying)

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

ELITE PHARMACEUTICALS INC /NV/

CIK 0001053369

Entity typeoperating

IncorporatedNJ

Related Parties

1

filerCIK 0001053369

Filing Metadata

Form type: 4
Filed: Apr 14, 8:00 PM ET
Accepted: Apr 15, 3:13 PM ET
Size: 10.8 KB

View on SEC.gov